Contribution of the DIAMA team to the WHO recommendations
The DIAMA consortium aims to validate new culture-free approaches to improve the management of drug-resistant tuberculosis (TB) in...
About Project
Nine africans partners are involved in this project such are Benin, Cameroon, Democratic Republic of Congo, Ethiopia, Guinea, Mali, Nigeria, Rwanda and Senegal.
In some African partners (Benin and Rwanda) with advanced molecular laboratories, the ‘Deeplex’ assay, a novel multiplex deep sequencing-based drug resistance diagnostic platform that simultaneously provides sequence information of genes that confer resistance to severals key anti-TB drugs has been implemented.
